Multiple fields may offer better esophagus sparing without increased probability of lung toxicity in optimized IMRT of lung tumors

被引:30
作者
Chapet, Olivier [1 ]
Fraass, Benedick A. [1 ]
Ten Haken, Randall K. [1 ]
机构
[1] Univ Michigan, Dept Radiat Oncol, Ann Arbor, MI 48109 USA
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2006年 / 65卷 / 01期
关键词
optimization; intensity-modulated radiation therapy; equivalent uniform dose; normal tissue complication probability; lung cancer;
D O I
10.1016/j.ijrobp.2005.12.028
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Purpose: To evaluate whether increasing numbers of intensity-modulated radiation therapy (IMRT) fields enhance lung-tumor dose without additional predicted toxicity for difficult planning geometries. Methods and Materials: Data from 8 previous three dimensional conformal radiation therapy (3D-CRT) patients with tumors located in various regions of each lung, but with planning target volumes (PTVs) overlapping part of the esophagus, were used as input. Four optimized-beamlet IMRT plans (1 plan that used the 3D-CRT beam arrangement and 3 plans with 3, 5, or 7 axial, but predominantly one-sided, fields) were compared. For IMRT, the equivalent uniform dose (EUD) in the whole PTV was optimized simultaneously with that in a reduced PTV exclusive of the esophagus. Normal-tissue complication probability-based costlets were used for the esophagus, heart, and lung. Results: Overall, IMRT plans (optimized by use of EUD to judiciously allow relaxed PTV dose homogeneity) result in better minimum PTV isodose surface coverage and better average EUD values than does conformal planning, dose generally increases with the number of fields. Even 7-field plans do not significantly alter normal-lung mean-dose values or lung volumes that receive more than 13, 20, or 30 Gy. Conclusion: Optimized many-field IMRT plans can lead to escalated lung-tumor dose in the special case of esophagus overlapping PTV, without unacceptable alteration in the dose distribution to normal lung. (c) 2006 Elsevier Inc.
引用
收藏
页码:255 / 265
页数:11
相关论文
共 62 条
[1]
First results of a phase I/II dose escalation trial in non-small cell lung cancer using three-dimensional conformal radiotherapy [J].
Belderbos, JSA ;
De Jaeger, K ;
Heemsbergen, WD ;
Seppenwoolde, Y ;
Baas, P ;
Boersma, LJ ;
Lebesque, JV .
RADIOTHERAPY AND ONCOLOGY, 2003, 66 (02) :113-120
[2]
FITTING OF NORMAL TISSUE TOLERANCE DATA TO AN ANALYTIC-FUNCTION [J].
BURMAN, C ;
KUTCHER, GJ ;
EMAMI, B ;
GOITEIN, M .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1991, 21 (01) :123-135
[3]
Esophagus sparing with IMRT in lung tumor irradiation: An EUD-based optimization technique [J].
Chapet, O ;
Thomas, E ;
Kessler, ML ;
Fraass, BA ;
Ten Haken, RK .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (01) :179-187
[4]
Photon beam relative dose validation of the DPM Monte Carlo code in lung-equivalent media [J].
Chetty, IJ ;
Charland, PM ;
Tyagi, N ;
McShan, DL ;
Fraass, BA ;
Bielajew, AF .
MEDICAL PHYSICS, 2003, 30 (04) :563-573
[5]
Reproducibility of lung tumor position and reduction of lung mass within the planning target volume using active breathing control (ABC) [J].
Cheung, PCF ;
Sixel, KE ;
Tirona, R ;
Ung, YC .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003, 57 (05) :1437-1442
[6]
The generalized equivalent uniform dose function as a basis for intensity-modulated treatment planning [J].
Choi, B ;
Deasy, J .
PHYSICS IN MEDICINE AND BIOLOGY, 2002, 47 (20) :3579-3589
[7]
Multiinstitutional phase II trial of paclitaxel, carboplatin, and concurrent radiation therapy for locally advanced non-small-cell lung cancer [J].
Choy, H ;
Akerley, W ;
Safran, H ;
Graziano, S ;
Chung, C ;
Williams, T ;
Cole, B ;
Kennedy, T .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (10) :3316-3322
[8]
Curran WJ, 2000, P AN M AM SOC CLIN, V19, P1891
[9]
Damen E, 2004, INT J RADIAT ONCOL, V60, pS198
[10]
Lethal pneumonitis in a phase I study of chemotherapy and IMRT for NSCLC: The need to investigate the accuracy of dose computation [J].
De Neve, W ;
De Wagter, C .
RADIOTHERAPY AND ONCOLOGY, 2005, 75 (02) :246-247